MLEC
Moolec Science SA
NASDAQ · Healthcare · Biotechnology · LU
$1.54
−8.63%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 0.27x
- P/E 2028E
- 0.05x
- P/S forward
- 0.84x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.14x
- Price / sales
- 0.01x
- Price / cash flow
- -0.13x
Enterprise value
- Enterprise value
- $23.3M
- EV / sales
- 0.07x
- EV / EBITDA
- -0.34x
- EV / EBIT
- -2.23x
- Market cap
- $3.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2025